The use of a potentially lifesaving, clot-busting drug — called tissue plasminogen activator (tPA) — to treat patients with ischemic stroke nearly doubled between 2003 and 2011, according to a large new study.
Source
The Karaoke Lowdown
The Karaoke Lowdown
The use of a potentially lifesaving, clot-busting drug — called tissue plasminogen activator (tPA) — to treat patients with ischemic stroke nearly doubled between 2003 and 2011, according to a large new study.
Source
